Literature DB >> 17047087

A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.

Rachael Z Stolzenberg-Solomon1, Reinhold Vieth, Azar Azad, Pirjo Pietinen, Philip R Taylor, Jarmo Virtamo, Demetrius Albanes.   

Abstract

Sun exposure is associated with lower death rates for pancreatic cancer in some ecological studies. Skin exposure to UVB light induces cutaneous production of precursors to 25-hydroxyvitamin D [25(OH)D]. Pancreatic islet and duct cells express 25(OH)D(3)-1alpha-hydroxylase that generates the biologically active 1,25(OH)(2) vitamin D form. Thus, 25(OH)D concentrations could affect pancreatic function and possibly pancreatic cancer etiology. We conducted a prospective nested case-control study in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention cohort of male Finnish smokers, ages 50 to 69 years at baseline, to test whether more adequate vitamin D status, as determined by prediagnostic serum 25(OH)D concentrations, was associated with lower pancreatic cancer risk. Two hundred incident exocrine pancreatic cancer cases that occurred between 1985 and 2001 (up to 16.7 years of follow-up) were matched by age and date of blood draw to 400 controls who were alive and free of cancer at the time the case was diagnosed. Odds ratios (OR) and 95% confidence intervals (95% CI) were calculated using conditional logistic regression. Higher vitamin D concentrations were associated with a 3-fold increased risk for pancreatic cancer (highest versus lowest quintile, >65.5 versus <32.0 nmol/L: OR, 2.92; 95% CI, 1.56-5.48, P(trend) = 0.001) that remained after excluding cases diagnosed early during follow-up. Contrary to expectations, subjects with higher prediagnostic vitamin D status had an increased pancreatic cancer risk compared with those with lower status. Our findings need to be replicated in other populations and caution is warranted in their interpretation and implication. Our results are intriguing and may provide clues that further the understanding of the etiology of this highly fatal cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17047087     DOI: 10.1158/0008-5472.CAN-06-1876

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  62 in total

Review 1.  Is dietary fat, vitamin D, or folate associated with pancreatic cancer?

Authors:  G V Sanchez; S J Weinstein; R Z Stolzenberg-Solomon
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.

Authors:  Brian M Wolpin; Kimmie Ng; Ying Bao; Peter Kraft; Meir J Stampfer; Dominique S Michaud; Jing Ma; Julie E Buring; Howard D Sesso; I-Min Lee; Nader Rifai; Barbara B Cochrane; Jean Wactawski-Wende; Rowan T Chlebowski; Walter C Willett; JoAnn E Manson; Edward L Giovannucci; Charles S Fuchs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-15       Impact factor: 4.254

Review 3.  Chemoprevention strategies for pancreatic cancer.

Authors:  Silvia D Stan; Shivendra V Singh; Randall E Brand
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-04       Impact factor: 46.802

4.  Vitamin D-binding protein and pancreatic cancer: a nested case-control study.

Authors:  Marina R Piper; D Michal Freedman; Kim Robien; William Kopp; Helen Rager; Ronald L Horst; Rachael Z Stolzenberg-Solomon
Journal:  Am J Clin Nutr       Date:  2015-04-22       Impact factor: 7.045

5.  Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers.

Authors:  Rachael Z Stolzenberg-Solomon; Stephanie Weinstein; Michael Pollak; Yuzhen Tao; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes
Journal:  Am J Epidemiol       Date:  2008-09-18       Impact factor: 4.897

6.  Predictors of vitamin D status in subjects that consume a vitamin D supplement.

Authors:  M A Levy; T McKinnon; T Barker; A Dern; T Helland; J Robertson; J Cuomo; T Wood; B M Dixon
Journal:  Eur J Clin Nutr       Date:  2014-07-16       Impact factor: 4.016

7.  Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2009-11

8.  Predictors of vitamin D biochemical status in a large sample of middle-aged male smokers in Finland.

Authors:  K E Brock; B I Graubard; D R Fraser; S J Weinstein; R Z Stolzenberg-Solomon; U Lim; J A Tangrea; J Virtamo; L Ke; K Snyder; D Albanes
Journal:  Eur J Clin Nutr       Date:  2010-01-06       Impact factor: 4.016

9.  Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Christian C Abnet; Yu Chen; Wong-Ho Chow; Yu-Tang Gao; Kathy J Helzlsouer; Loïc Le Marchand; Marjorie L McCullough; James M Shikany; Jarmo Virtamo; Stephanie J Weinstein; Yong-Bing Xiang; Kai Yu; Wei Zheng; Demetrius Albanes; Alan A Arslan; David S Campbell; Peter T Campbell; Richard B Hayes; Ronald L Horst; Laurence N Kolonel; Abraham M Y Nomura; Mark P Purdue; Kirk Snyder; Xiao-Ou Shu
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

Review 10.  The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control.

Authors:  F C Campbell; Haibo Xu; M El-Tanani; P Crowe; V Bingham
Journal:  Biochem Pharmacol       Date:  2009-09-06       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.